• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Delivering safe and effective stereotactic body radiation therapy for patients with centrally located early stage non-small cell lung cancer.

作者信息

Haseltine Justin M, Rimner Andreas, Shepherd Annemarie F, Wu Abraham J, Gelblum Daphna Y, Shaverdian Narek, Gomez Daniel R, Simone Charles B

机构信息

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; New York Proton Center, New York, NY, USA.

出版信息

Chin Clin Oncol. 2020 Jun;9(3):39. doi: 10.21037/cco.2019.12.17. Epub 2020 Jan 15.

DOI:10.21037/cco.2019.12.17
PMID:32008333
Abstract
摘要

相似文献

1
Delivering safe and effective stereotactic body radiation therapy for patients with centrally located early stage non-small cell lung cancer.为中心型早期非小细胞肺癌患者提供安全有效的立体定向体部放射治疗。
Chin Clin Oncol. 2020 Jun;9(3):39. doi: 10.21037/cco.2019.12.17. Epub 2020 Jan 15.
2
The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non-Small-Cell Lung Cancer Continues.针对无法手术的中央型非小细胞肺癌，寻找最佳立体定向体部放疗剂量的研究仍在继续。
J Clin Oncol. 2019 Oct 10;37(29):2697-2699. doi: 10.1200/JCO.19.01330. Epub 2019 Aug 29.
3
Immunotherapy plus stereotactic radiation therapy improves event-free survival in early-stage non-small cell lung cancer.免疫疗法联合立体定向放射治疗可提高早期非小细胞肺癌的无事件生存率。
Cancer. 2023 Dec 1;129(23):3680. doi: 10.1002/cncr.35088.
4
Stereotactic radiosurgery for early stage non-small cell lung cancer: rationale, patient selection, results, and complications.早期非小细胞肺癌的立体定向放射外科治疗：原理、患者选择、结果及并发症
Semin Thorac Cardiovasc Surg. 2008 Winter;20(4):290-7. doi: 10.1053/j.semtcvs.2008.12.001.
5
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.立体定向体部放疗和立体定向体部质子治疗高危、不可手术、早期非小细胞肺癌的 2 期研究。
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):558-563. doi: 10.1016/j.ijrobp.2018.02.022. Epub 2018 Mar 2.
6
Stereotactic Body Radiation Therapy versus Thermal Ablation for Early Stage Non-Small Cell Lung Cancer.立体定向体部放射治疗与热消融治疗早期非小细胞肺癌的比较。
Radiology. 2019 Feb;290(2):574-575. doi: 10.1148/radiol.2018182310. Epub 2019 Jan 1.
7
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.立体定向消融放疗治疗中央型早期非小细胞肺癌：我们的经验教训。
J Thorac Oncol. 2015 Apr;10(4):577-85. doi: 10.1097/JTO.0000000000000453.
8
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.来自RSSearch(®)患者登记处的关于中心型早期非小细胞肺癌或肺转移瘤的立体定向体部放射治疗
Radiat Oncol. 2015 May 15;10:113. doi: 10.1186/s13014-015-0417-5.
9
Stereotactic radiotherapy for early-stage (T1-2N0) small cell lung cancer: Where are we now and where are we going?早期（T1-2N0）小细胞肺癌的立体定向放射治疗：我们目前的状况及未来走向？
Lung Cancer. 2021 Oct;160:187-189. doi: 10.1016/j.lungcan.2021.07.019. Epub 2021 Aug 3.
10
Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer.立体定向放射治疗：改变 I 期非小细胞肺癌的治疗模式。
Curr Opin Oncol. 2011 Mar;23(2):133-9. doi: 10.1097/CCO.0b013e328341ee11.

引用本文的文献

1
Stereotactic body proton therapy for non-small cell lung cancer: Clinical indications and recommendations.立体定向体部质子治疗非小细胞肺癌：临床适应证与推荐意见
J Radiosurg SBRT. 2023;9(1):17-32.
2
Association between albumin-to-globulin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: a retrospective cohort study.白蛋白-球蛋白比值与安罗替尼治疗晚期非小细胞肺癌患者总生存风险的关系：一项回顾性队列研究。
BMC Pulm Med. 2023 Jul 25;23(1):275. doi: 10.1186/s12890-023-02574-6.
3
The efficacy and safety of Zengxiao Jiandu decoction combined with definitive concurrent chemoradiotherapy for unresectable locally advanced non-small cell lung cancer: a randomized, double-blind, placebo-controlled clinical trial.
增消减毒汤联合根治性同步放化疗治疗不可切除局部晚期非小细胞肺癌的疗效与安全性：一项随机、双盲、安慰剂对照临床试验
Ann Transl Med. 2022 Jul;10(14):800. doi: 10.21037/atm-22-2814.
4
inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients.抑制肺腺癌的侵袭能力并改善患者的预后。
J Thorac Dis. 2022 Jul;14(7):2652-2664. doi: 10.21037/jtd-22-842.
5
Combination of albumin concentration and neutrophil-to-lymphocyte ratio for predicting overall survival of patients with non-small cell lung cancer.白蛋白浓度与中性粒细胞与淋巴细胞比值联合用于预测非小细胞肺癌患者的总生存期
J Thorac Dis. 2021 Sep;13(9):5508-5516. doi: 10.21037/jtd-21-1320.